# Nicotine Polacrilex

NDC: 55910-933
Generic name: Nicotine Polacrilex
Labeler / Manufacturer: Dolgencorp, Inc. (DOLLAR GENERAL & REXALL)
Product type: HUMAN OTC DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: GUM, CHEWING
Routes: ORAL
Marketing started: 20231025
Marketing ended: 20270430
FDA application: ANDA204833

## Active ingredients

- NICOTINE: 4 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"55910-933"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=55910-933
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=ee883114-35ac-4b81-b8f1-4903d646dd84